Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Cyclacel Pharmaceuticals Inc    CYCC   US23254L3069

 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
10/27/2014 10/28/2014 10/29/2014 10/30/2014 10/31/2014 Date
3.55(c) 3.58(c) 3.4(c) 3.34(c) 3.43 Last
105 730 142 766 64 284 358 180 10 145 Volume
+3.20% +0.85% -5.03% -1.76% +2.69% Change
More quotes
Company
Cyclacel Pharmaceuticals, Inc. is a biopharmaceutical company.It engages in developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious diseases.Its most advance product candidate, is the subject of SEAMLESS, a phase 3 trail being... 
Surperformance© rating of Cyclacel Pharmaceuticals I
Trading Rating : - Investor Rating :
More about the company
Chart CYCLACEL PHARMACEUTICALS I
Duration : Period :
Cyclacel Pharmaceuticals I Technical Analysis Chart | CYCC | US23254L3069 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 0,93 M
EBIT 2014 -24,1 M
Net income 2014 -21,8 M
Debt 2014 -
Yield 2014 -
Sales 2015 0,25 M
EBIT 2015 -29,2 M
Net income 2015 -27,5 M
Debt 2015 -
Yield 2015 -
PER 2014 -
PER 2015
Capi. / Sales 2014 81,8x
Capi. / Sales 2015 303x
Capitalization 75,7 M
More Financials
Latest news on CYCLACEL PHARMACEUTICALS I
10/09 CYCLACEL PHARMACEUTICALS : Announces Data Safety Monitoring Board Recommendation..
09/26 CYCLACEL PHARMACEUTICALS : Regulation FD Disclosure, Financial Statements and Ex..
09/19 CYCLACEL PHARMACEUTICALS : to Present at BioCentury's Newsmakers in the Biotech ..
09/18 CYCLACEL PHARMACEUTICALS : CYC065 CDK Inhibitor Demonstrates Therapeutic Potenti..
09/11 CYCLACEL PHARMACEUTICALS : Change in Directors or Principal Officers, Other Even..
09/11 CYCLACEL PHARMACEUTICALS : Appoints Samuel L. Barker, Ph.D., to Board of Directo..
09/10 CYCLACEL PHARMACEUTICALS : Announces Abstract Selected for Presentation at Socie..
09/02 CYCLACEL PHARMACEUTICALS : to Present at 16th Rodman & Renshaw Annual Global Inv..
08/12 CYCLACEL PHARMACEUTICALS : Management's Discussion and Analysis of Financial Con..
08/12 CYCLACEL PHARMACEUTICALS : Results of Operations and Financial Condition, Financ..
08/12 Cyclacel Pharmaceuticals Reports Second Quarter 2014 Financial Results
08/06 CYCLACEL PHARMACEUTICALS : to Release 2014 Second Quarter Financial Results
More news


Comments 
Advertisement
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF